Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 4, 2002, Pages 349-353

  Buyukasik, Yahya ^a   Karakus, S ^a   Goker, H ^a   Haznedaroglu, I C ^a   Ozatli, D ^a   Sayinalp, N ^a   Ozcebe, O I ^a   Dundar, S V ^a   Kirazli, S ^a  

^a NONE   (Turkey)

Author keywords

PFA 100; Platelet function disorders; Von Willebrand disease

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; HEMOGLOBIN;

ALGORITHM; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIAGNOSTIC VALUE; GLANZMANN DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; VON WILLEBRAND DISEASE;

ALGORITHMS; CASE-CONTROL STUDIES; DECISION TREES; DIAGNOSTIC EQUIPMENT; HUMANS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THROMBASTHENIA; VON WILLEBRAND DISEASE;

EID: 0036592728     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200206000-00011     Document Type: Article

References (13)

1. The bleeding time does not predict surgical bleeding
2. Relative value of diagnostic studies for von Willebrand disease
3. PFA-100 system: A new method for assessment of platelet dysfunction
4. Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy: A review of analytical variables, benefits and limitations
5. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center
6. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
7. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease
8. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders
9. Platelet function disorders
10. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion
11. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function
12. Influence of ABO blood groups on primary hemostasis
13. Evaluation acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100™): Influence of hematocrit elevation